RIPK2 and asthma: The administration of the selective GSK583 RIPK2 inhibitor via the mice diet prior to and during the HDM sensitization phase of an acute asthma model resulted in a reduction of the eosinophilia, neutrophilia, and histopathology features of the asthmatic mouse.